CTNM
CONTINEUM THE-A (CTNM)
NASDAQ
$12.47+$0.09 (+0.73%)
Price as of Jun 03, 2026 4:04 PM EDT
  • $441.4M
    Market Cap
  • 161.18%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
N/A
N/A
0
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
Research and Development Expense
-51.5M
+34.10%
-38.4M
N/A
Depreciation and Amortization Expense
323,000
+25.19%
258,000
N/A
Total Operating Expenses
68.1M
+33.73%
50.9M
N/A
Operating Profit
-68.1M
+33.73%
-50.9M
N/A
Interest Income
8.2M
-7.40%
8.9M
N/A
Interest Expense
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
8.2M
-7.40%
8.9M
N/A
Total Nonoperating Income and Expense
8.1M
-6.43%
8.6M
N/A
Income before Taxes
-68.1M
+61.06%
-42.3M
N/A
Income Taxes
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-60.0M
+41.93%
-42.3M
N/A
Net Income from Continuing Operations Applicable to Common
-60.0M
+41.93%
-42.3M
N/A
Basic EPS and Net Income
-2.17
-0.46%
-2.18
N/A
Diluted EPS and Net Income
-2.17
-0.46%
-2.18
N/A
Basic Weighted Average Shares
27.7M
+43.14%
19.4M
N/A
Diluted Weighted Average Shares
27.7M
+43.14%
19.4M
N/A
Balance Sheet
Cash and Cash Equivalents
75.6M
+244.54%
21.9M
N/A
Short-Term Investments
187.3M
+2.45%
182.8M
N/A
Cash and Cash Equivalents and Short-Term Investments
262.9M
+28.39%
204.8M
N/A
Total Current Assets
267.9M
+29.81%
206.4M
N/A
Accumulated Depreciation
2.0M
+14.33%
1.7M
N/A
Property and Plant and Equipment and Net
830,000
-16.08%
989,000
N/A
Total Long-Term Assets
256,000
+8,433.33%
3,000
N/A
Total Assets
276.6M
+29.97%
212.8M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
Total Current Liabilities
9.7M
-2.31%
10.0M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
5.9M
N/A
0
N/A
Total Liabilities
15.7M
+5.90%
14.8M
N/A
Retained Earnings
-177.4M
+51.09%
-117.4M
N/A
Total Stockholders Equity
261.0M
+31.77%
198.1M
N/A
Total Shares Outstanding
31.2M
+20.82%
25.9M
N/A
Cash Flow
Cash from Operating Activities
-55.3M
+68.40%
-32.8M
N/A
Capital Expenditures
231,000
-55.06%
514,000
N/A
Cash from Investing Activities
-3.7M
-94.68%
-69.7M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
112.7M
+3.38%
109.0M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
Return on Assets
-24.51%
N/A
N/A
N/A
Return on Equity
-26.13%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
Current Ratio
27.50
N/A
N/A
N/A
Cash Ratio
7.76
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow